在中国出海赚外快的行业里面,电动汽车EV这两年非常吸睛,但实则生物医药科技行业才是真正闷声赚大钱的财主。相较起来,EV就是个还在穿纸尿裤的小不点。

China is making more money on Biotech than EVs from overseas mkt.

China struck out-licensing deals of up to $136B in 2025 w/ $7B up-front payment (150x vs 2019). Dec saw 15 deals of $16B in value.

Biggest deals went to HengRui, GeneQuantum & innovent. AI is widely used.

信息来源 Source Ref.

irgiwgnk.webp lfwk4su3.webp do13abjm.webp ssjcpvq4.webp